[1]
|
Stone, M.J., Hayward, J.A., Huang, C., Huma, Z.E. and Sanchez, J. (2017) Mechanisms of Regulation of the Chemokine-Receptor Network. International Journal of Molecular Sciences, 18, Article No. 342.
https://doi.org/10.3390/ijms18020342
|
[2]
|
冉黎婧, 史明霞, 洪敏. 间充质干细胞归巢机制研究进展[J]. 医学研究生学报, 2014(4): 423-426.
|
[3]
|
Janssens, R., Proost, P. and Sofie, S. (2018) Pathological Roles of the Homeostatic Chemokine CXCL12. Cytokine & Growth Factor Reviews, 44, 51-68. https://doi.org/10.1016/j.cytogfr.2018.10.004
|
[4]
|
Long, Y., Jiang, Y., Zeng, J., Dang, Y., Chen, Y., Lin, J., Wei, H., Xia, H., Long, J., Luo, C., Chen, Z., Huang, Y. and Li, M. (2020) The Expression and Biological Function of Chemokine CXCL12 and Receptor CXCR4/CXCR7 in Placenta Accreta Spectrum Disorders. Journal of Cellular and Molecular Medicine, 24, 3167-3182.
https://doi.org/10.1111/jcmm.14990
|
[5]
|
Sun, X., Cheng, G., Hao, M., Zheng, J., Zhou, X., Zhang, J., et al. (2010) CXCL12/CXCR4/CXCR7 Chemokine Axis and cancer Progression. Cancer and Metastasis Reviews, 29, 709-722. https://doi.org/10.1007/s10555-010-9256-x
|
[6]
|
Harriague, J., Thelen, M., Infantino, S., Chow, K.Y.C., Harriague, J., Moepps, B., et al. (2005) The Chemokine SDF-1/CXCL12 Binds to and Signals through the Orphan Receptor RDC1 in T Lymphocytes. The Journal of Biological Chemistry, 280, 35760-35766. https://doi.org/10.1074/jbc.M508234200
|
[7]
|
Benredjem, B., Mélanie, G., Rhainds, D., St.-Onge, G. and Heveker, N. (2017) Mutational Analysis of Atypical Chemokine Receptor 3 (ACKR3/CXCR7) Interaction with Its Chemokine Ligands CXCL11 and CXCL12. Journal of Biological Chemistry, 292, 31-42. https://doi.org/10.1074/jbc.M116.762252
|
[8]
|
Chen, Q., Zhang, M., Li, Y., Xu, D., Wang, Y., Song, A., et al. (2015) CXCR7 Mediates Neural Progenitor Cells Migration to CXCL12 Independent of CXCR4. Stem Cells, 33, 2574-2585. https://doi.org/10.1002/stem.2022
|
[9]
|
Wang, C., Chen, W. and Shen, J. (2018) CXCR7 Targeting and Its Major Disease Relevance. Frontiers in Pharmacology, 9, Article No. 641. https://doi.org/10.3389/fphar.2018.00641
|
[10]
|
袁泉, 许丞, 张翔, 卢东, 张捷. 膀胱癌组织中CXCR4和CXCR7的表达及临床意义[J]. 现代生物医学进展, 2016, 16(27): 5273-5275, 5292.
|
[11]
|
Tarnowski, M., Liu, R., Wysoczynski, M., Ratajczak, J., Kucia, M. and Ratajczak, M.Z. (2010) CXCR7: A New SDF-1-Binding Receptor in Contrast to Normal CD34+ Progenitors is Functional and Is Expressed at Higher Level in Human Malignant Hematopoietic Cells. European Journal of Haematology, 85, 472-483.
https://doi.org/10.1111/j.1600-0609.2010.01531.x
|
[12]
|
Wang, J., Shiozawa, Y., Wang, J., Wang, Y., Jung, Y., Pienta, K.J., et al. (2008) The Role of CXCR7/RDC1 as a Chemokine Receptor for CXCL12/SDF-1 in Prostate Cancer. Journal of Biological Chemistry, 283, 4283-4294.
https://doi.org/10.1074/jbc.M707465200
|
[13]
|
金栋. CXCL12/CXCR7轴对人肝癌细胞增殖与迁移能力的影响[D]: [硕士学位论文]. 银川: 宁夏医科大学, 2011.
|
[14]
|
Long, P., Sun, F., Ma, Y. and Huang, Y. (2016) Inhibition of CXCR4 and CXCR7 for Reduction of Cell Proliferation and Invasion in Human Endometrial Cancer. Tumor Biology, 37, 7473-7480.
https://doi.org/10.1007/s13277-015-4580-y
|
[15]
|
辛琪, 张娜, 温丽坤, 张勤, 张传山. 趋化因子受体CXCR7通过VEGF促进胃癌生长[J]. 世界华人消化杂志, 2018, 26(11): 639-647. https://doi.org/10.11569/wcjd.v26.i11.639
|
[16]
|
Stacer, A.C., Fenner, J., Cavnar, S.P., Xiao, A., Zhao, S., Chang, S.L., et al. (2016) Endothelial CXCR7 Regulates Breast Cancer Metastasis. Oncogene, 35, 1716-1724. https://doi.org/10.1038/onc.2015.236
|
[17]
|
辛琪, 张勤, 张娜, 温丽坤, 刘贵秋, 张传山, 等. 趋化因子配体12、趋化因子受体7在肠型胃癌中的表达与淋巴结和肝脏转移的关系[J].中华消化杂志, 2016, 36(11): 740-745.
|
[18]
|
Wang, H., Tao, L., Qi, K., Zhang, H., Feng, D., Wei, W., et al. (2015) CXCR7 Functions in Colon Cancer Cell Survival and Migration. Experimental & Therapeutic Medicine, 10, 1720-1724. https://doi.org/10.3892/etm.2015.2748
|
[19]
|
Wang, H.X., Tao, L.Y., Qi, K., Zhang, H.Y., Feng, D., Wei, W.J., et al. (2015) Role of CXC Chemokine Receptor Type 7 in Carcinogenesis and Lymph Node Metastasis of Colon Cancer. Molecular & Clinical Oncology, 3, 1229-1232. https://doi.org/10.3892/mco.2015.643
|
[20]
|
Sanchez-Martin, L., Estecha, A., Samaniego, R., Sánchez-Ramón, S., Ángel Vega, M. and Sánchez-Mateos, P. (2011) The Chemokine CXCL12 Regulates Monocyte-Macrophage Differentiation and RUNX3 Expression. Blood, 117, 88-97. https://doi.org/10.1182/blood-2009-12-258186
|
[21]
|
李迪诺. CXCR7-CXCL12生物学轴在胃癌血管生成及侵袭转移中的分子机制研究[D]: [博士学位论文]. 济南: 山东大学, 2017.
|
[22]
|
Liu, Y., Carson-Walter, E. and Walter, K.A. (2015) Targeting Chemokine Receptor CXCR7 Inhibits Glioma Cell Proliferation and Mobility. Anticancer Research, 35, 53-64.
|
[23]
|
Lin, L., Han, M.M., Wang, F., Xu, L.-L., Yu, H.-X. and Yang, P.-Y. (2014) CXCR7 Stimulates MAPK Signaling to Regulate Hepatocellular Carcinoma Progression. Cell Death & Disease, 5, e1488.
https://doi.org/10.1038/cddis.2014.392
|
[24]
|
罗旭玮, 赵凯, 郭青龙. CXCR7的生物学功能及其在肿瘤发生发展中的作用研究进展[J]. 药学进展, 2016, 40(9): 695-699.
|
[25]
|
于利影, 黄红艳, 徐桂涛, 曹仕琼, 王坤. 趋化因子受体CXCR7在结直肠癌组织中的表达及临床意义[J]. 临床消化病杂志, 2016, 28(4): 235-239.
|
[26]
|
张建庆, 王珍. 趋化因子受体7在结直肠癌组织中的表达及其与患者远期生存率的相关性[J]. 中国煤炭工业医学杂志, 2019, 22(1): 75-78.
|
[27]
|
邱明远, 李健文, 叶青, 郑民华, 刘炳亚. RNA干扰CXCR7基因对结肠癌SW1116细胞增殖及迁移的影响[J]. 肿瘤, 2011, 31(5): 412-416.
|
[28]
|
王鑫, 陈玲, 孙飞, 陆航. RNAi沉默CXCR7对人结肠癌细胞SW620特异性靶向抑制的实验研究[J]. 中国生物工程杂志, 2014, 34(2): 14-20.
|
[29]
|
Guillemot, E., Karimdjee-Soilihi, B., Pradelli, E., Benchetrit, M., Goguet-Surmenian, E., Millet, M.-A., et al. (2012) CXCR7 Receptors Facilitate the Progression of Colon Carcinoma within Lung Not within Liver. The British Journal of Cancer, 107, 1944-1949. https://doi.org/10.1038/bjc.2012.503
|